Microbix Biosystems Inc. saw a notable price movement this week amidst limited news coverage.
This week, Microbix Biosystems Inc. (MBX.TO) experienced fluctuations in its stock price, closing at C$0.30 on Friday. The stock was down 6.25% for the day but up 3.45% over the past week. Investors are closely watching the company's financial performance and upcoming announcements as it navigates the health care sector.
Advertisement
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeAdvertisement
Market cap
$44.00M
52W high
$0.32
52W low
$0.21
1W change
+3.45%
Beta
0.57
Analyst Price Targets
Based on analyst covering MBX
Wall Street analysts forecast MBX stock price to rise 33.3% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+33.3% Upside
Current Price
C$0.30
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
43.1%
Annualized
90-Day Vol
48.5%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.36
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.32 | C$0.27 – C$0.37 |
| 60 trading days | C$0.34 | C$0.27 – C$0.42 |
| 90 trading days | C$0.36 | C$0.28 – C$0.46 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Despite a recent decline, Microbix's year-to-date performance remains positive, reflecting a 25.00% increase. Investors should consider the company's upcoming financial results and market position.
C$0.30 Closing Price; 6.25% Daily Drop
The stock has shown a significant increase in trading volume, with 8,000 shares traded on Friday compared to the 20-day average of 23,671 shares, suggesting heightened investor interest.
Bull case
Microbix's recent Q1 2026 financial results showed a 13% increase in revenues, indicating potential growth and recovery in sales after previous setbacks. The scheduled release of Q2 results and ongoing improvements in manufacturing capabilities may further boost investor confidence.
Bear case
The stock's volatility and recent price drop may raise concerns among investors, especially due to its negative profit margin and return on equity. Additionally, the company's limited media coverage and market cap could pose risks for potential investors.
Recent Price Action
Microbix Biosystems Inc. closed at C$0.30 on Friday, marking a 6.25% decline for the day. However, the stock has seen a weekly gain of 3.45%. Year-to-date, the stock has appreciated by 25.00%, reflecting a positive outlook despite recent fluctuations.
Company News and Developments
Advertisement
This week, Microbix did not release any major news. However, previous headlines indicate that the company reported Q1 2026 financial results, showcasing a revenue increase of 13% compared to the previous quarter. Looking ahead, Microbix has scheduled the release of its Q2 2026 financial results for May 14, 2026, which may provide further insights into its operational performance.
Technical Picture
Currently, Microbix's stock is trading at its 50-day moving average of C$0.30, slightly above its price, indicating a potential support level. The 200-day moving average stands at C$0.26, showing a 17.3% increase compared to the current price. The stock's 52-week range is between C$0.21 and C$0.32, with the current price at 82% of this range, suggesting that it is trading towards the higher end of its historical performance.
Insider Activity
No recent insider activity has been reported for Microbix Biosystems Inc., indicating that there have been no significant trades by executives or board members in the recent past.
Price Action Summary
Microbix Biosystems Inc. closed at C$0.30, reflecting a 6.25% decline for the day. Investors will be keenly watching the upcoming financial results and any potential announcements that could impact the stock's performance.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
